Effect of Empagliflozin on Ventricular Repolarization.
NCT04117763
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Coronary Heart Disease
Arrythmia, Cardiac
Interventions
DRUG:
Empagliflozin 25 MG
Sponsor
University of Sao Paulo